Irritable bowel syndrome overview: Difference between revisions
No edit summary |
|||
| Line 17: | Line 17: | ||
==Historical Perspective== | ==Historical Perspective== | ||
[[Irritable bowel syndrome|Irritable Bowel syndrome(IBS)]] was first mentioned in the Rocky Mountain Medical Journal in 1950. [[Irritable bowel syndrome|IBS]] was described as a [[Psychosomatic illness|psychosomatic]] disorder, not explained by any [[Biochemistry|biochemical]] or [[Structural biology|structural]] abnormalities. Apley and Nash conducted a famous study on 1000 children in Bristol, United Kingdom and were the first to describe Recurrent [[Abdominal pain|Abdominal Pain]] (RAP) as the predominant feature of [[Irritable bowel syndrome|IBS]]. In 1978, the first [[Diagnostic|diagnostic criteria]] i.e. the [[Manning criteria|Manning]] [[Criterion|criteria]] was described. It did not specify any required duration for the symptoms of [[Irritable bowel syndrome|IBS]]. The subsequent [[Criterion|criteria]] saw a reduction in the required duration of [[Symptom|symptoms]] to facilitate early [[diagnosis]] and [[Treatment Planning|treatment]]. In Rome in 1995, an international group of gastroenterologists defined the [[Diagnosis|diagnostic criteria]] for IBS and this was published in 1999 under the title of the Rome II [[Criterion|criteria]]. This [[Criterion|criteria]] underwent modification and was described as the Rome III [[Criterion|criteria]]. Since June 2016, the [[Criterion|criteria]] being followed is the Rome IV [[Criterion|criteria]]. | |||
==Classification== | ==Classification== | ||
Revision as of 14:38, 27 November 2017
| https://https://www.youtube.com/watch?v=9f5wxYW0Z3k%7C350}} |
|
Irritable bowel syndrome Microchapters |
|
Differentiating Irritable bowel syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Irritable bowel syndrome overview On the Web |
|
American Roentgen Ray Society Images of Irritable bowel syndrome overview |
|
Risk calculators and risk factors for Irritable bowel syndrome overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Irritable bowel syndrome is a functional bowel disorder characterized by abdominal pain and changes in bowel habits which are not associated with any abnormalities seen on routine clinical testing. The disease is fairly common and makes up 20–50% of visits to gastroenterologists. Lower abdominal pain, and bloating associated with alteration of bowel habits and abdominal discomfort relieved with defecation are the most frequent symptoms. The abdominal pain type is usually described in a patient as either diarrhea-predominant (IBS-D), constipation-predominant (IBS-C) or IBS with alternating stool pattern (IBS-A). In some individuals, IBS may have an acute onset and develop after an infectious illness characterised by two or more of the following: fever, vomiting, acute diarrhea or positive stool culture. This post-infective syndrome has consequently been termed "post-infectious IBS" (IBS-PI) and is acute onset Rome II criteria positive. This condition is more homogeneous, being mostly IBS-D and is drawing much clinical investigation.
Chronic functional abdominal pain (CFAP) is quite similar to, but less common than IBS. CFAP can be diagnosed if there is no change in bowel habits.
Because of the name, IBS can be confused with inflammatory bowel disease (IBD).
Historical Perspective
Irritable Bowel syndrome(IBS) was first mentioned in the Rocky Mountain Medical Journal in 1950. IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. Apley and Nash conducted a famous study on 1000 children in Bristol, United Kingdom and were the first to describe Recurrent Abdominal Pain (RAP) as the predominant feature of IBS. In 1978, the first diagnostic criteria i.e. the Manning criteria was described. It did not specify any required duration for the symptoms of IBS. The subsequent criteria saw a reduction in the required duration of symptoms to facilitate early diagnosis and treatment. In Rome in 1995, an international group of gastroenterologists defined the diagnostic criteria for IBS and this was published in 1999 under the title of the Rome II criteria. This criteria underwent modification and was described as the Rome III criteria. Since June 2016, the criteria being followed is the Rome IV criteria.